Mealtime tablets (glinides) are used to manage type 2 diabetes in adults as a phase two or three medicine together with lifestyle management and metformin or other blood sugar-lowering medicine or basal insulin. They can also be used on their own, if metformin or other blood sugar-lowering medicines are not suitable. Meal-time tablets are known as glinides.
People with MODY (Mature Onset Diabetes in the Young) diabetes are another significant user group for which glinides combined with lifestyle management may be a sufficient treatment. With new pharmaceutical products becoming available, the use of glinides to manage type 2 diabetes has become less common compared to previous years. The products used in Finland (7/2023), include repaglinide and, subject to a special permit, nateglinide.